EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS197-10244 
Organism
Homo sapiens 
Tissue/cell
ZR75-30 
Coordinate
chr19:6587870-6590110 
Target genes
TF binding sites/motifs
Number: 18             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr19:6589344-6589362CCTTCCTTCTTCTCTTTC-6.07
EWSR1-FLI1MA0149.1chr19:6589332-6589350CCCTCTCTCCTTCCTTCC-6.62
EWSR1-FLI1MA0149.1chr19:6589340-6589358CCTTCCTTCCTTCTTCTC-7.08
EWSR1-FLI1MA0149.1chr19:6589336-6589354CTCTCCTTCCTTCCTTCT-7.37
EWSR1-FLI1MA0149.1chr19:6589362-6589380TTTTCCTTCCTTCCTTTC-7.66
EWSR1-FLI1MA0149.1chr19:6589366-6589384CCTTCCTTCCTTTCTTTC-8.57
IRF1MA0050.2chr19:6589374-6589395CCTTTCTTTCTTTTTCTTTTC+6.31
IRF1MA0050.2chr19:6589293-6589314TTCTTCTTTCTTTTTCCTTTC+6.33
ZNF263MA0528.1chr19:6589335-6589356TCTCTCCTTCCTTCCTTCTTC-6.05
ZNF263MA0528.1chr19:6590046-6590067TCTACCTCTCCTTCCTTCTCT-6.14
ZNF263MA0528.1chr19:6589971-6589992CTCCCTATCTCTCCCTCCCTC-6.15
ZNF263MA0528.1chr19:6590043-6590064CTTTCTACCTCTCCTTCCTTC-6.16
ZNF263MA0528.1chr19:6589836-6589857CTTTCTTTCCCCTTCTTCTCC-6.1
ZNF263MA0528.1chr19:6589979-6590000CTCTCCCTCCCTCTCTCCCTC-6.35
ZNF263MA0528.1chr19:6589332-6589353CCCTCTCTCCTTCCTTCCTTC-6.47
ZNF263MA0528.1chr19:6589324-6589345ACCTCCCTCCCTCTCTCCTTC-6.54
ZNF263MA0528.1chr19:6589316-6589337TCTCTCTCACCTCCCTCCCTC-6.57
ZNF263MA0528.1chr19:6589328-6589349CCCTCCCTCTCTCCTTCCTTC-7.59
Number of super-enhancer constituents: 6             
IDCoordinateTissue/cell
SE_32584chr19:6586608-6594939GM12878
SE_58692chr19:6572434-6609995Ly1
SE_59094chr19:6575851-6609908Ly3
SE_60218chr19:6575317-6605972Ly4
SE_61267chr19:6576037-6605818HBL1
SE_61827chr19:6572254-6609891Toledo
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr1965894296589697
chr1965887796589068
chr1965881246588275
Number: 1             
IDChromosomeStartEnd
GH19I006587chr1965870166588540
Enhancer Sequence
CCATGACCAG CTAATTTTCA AAATTTTGTT CTAGAGATGG TGGTCTTGCT ATGTTTCCCA 60
AGAAACATAG TCTAGAACTC CTGGGCTCAA GCGATCCTCC CACCTCAGCC TCCCAAAGCG 120
CTGGGATCAC AGCCGGGAGC CAAGGTCCTC GGCTATATTT CACGTGTTTC ATCTCAGCGT 180
CTCCTGTCTC CGCAACTTAT CTGACTGACA CACCTGAGCC TCACTCTCCT CCTCACTCAA 240
GGCTCTCCTG GAGACTGGCT ATCTTGTTAG GAAGGAACTG AACGGGGTCA AACAGGAGCC 300
CCAAGGGTGT TTACCAGGCT TTGCAAATTT CCTGTAAGAG TGACACCTGG TCCCCTGTCA 360
CACACTTAGG CATGATATCA TCCACCAGAA GAAAGAGCTG TCCTGTGAAA GACACTGTCA 420
ACACCTGTGG CCACCACCCC TGGTGCCCCA TCGATGTGGG GCTGGACAGC CACTCTCCAG 480
AAAGGGGCCT CAAGACCAAA TTACAGGAAA AATATGGCAA AGGCCGGGGA GGGGGGGAAG 540
ATATATCAGG GGTCAGAGAC CCAAGGAGAA GAGAGAGCAA CAAAGGTCCC TTCCATTACA 600
AAATGGAAGG AACAAAACAC GCAAGCGTGC AGTAATTTTA GTCTCTGGGG ATGAACCGTG 660
GAAAAACAGA AGAGGAAGAA GCGTTCGAGA GAGGCTGGGA GGAGGTAGAG ACTTCCACCT 720
AGAGCAGAAC TGTTCATTTC TTCTCCCTCA AGGCTTCTTG CCAATGCCAC CCACTCAGAT 780
ACCACCCCCC CACCCGACCG CCGCGACTCC ACTTTAAATG AAAATCCCCA ACCCTGGCAT 840
GCCCGGATTC CCCACCCACC TCCTTGCCTG ATTTTTTCTC TAAAACCTGC TCTTGGCCTG 900
TTTTACTCTA CGTGGCATTG CTCTGTTTTT CACATGTTCG TTTTTATTTT TTTGGTCATC 960
TCCTCCTCGG TAGGAGTGAT AGTAGAAGGG AAGCTCACCA GGCAGGGATT TCTGTCTGTT 1020
TTGTGCGCGA CTGCAGTACC GGAACAGTGC CTGCCCACTG CAGATGTATA ATTAGTGCTT 1080
GTAGCATGAA TGGAGGAAGG GTAGCCTTTC CTGTGAGCGT TTTCGTTTAC TAACAAAACC 1140
CCTTTGATTC TTCCAAGGGA GGAGATCGAA TGTGAAGGAC TGAGAGGGAA AGGGAGAGAA 1200
AGGTAGTGGA TGCCCAGAAA CACAAACCTG CTCGCTCTCT CTCTCCTCTC TCTCTCTCTC 1260
GTTCTCTCCC TTTTCCTTTT TCTCTTGGGA ATGATCTCTT TCTCCCCCGC CCTGTTTTTC 1320
TTCTTCCCCC TCTCTGTCTC TGTCTCTTCC TCTCTGTTAT TCTCCTTCTC TTTTCCTCTC 1380
TCTGGCTTTC TTTCTTTTCT TTCTCTTATT TCTTTTTTTC TCTTTCTTCT TTCTTTTTCC 1440
TTTCTCTCTC TCTCACCTCC CTCCCTCTCT CCTTCCTTCC TTCTTCTCTT TCTTTTCCTT 1500
CCTTCCTTTC TTTCTTTTTC TTTTCCTTTC TTCTTTTTAT TTATTTATTT GACAGAATCT 1560
CCCTCTGTCA CCCAGGCTGG AGAGCAGTGC CATTATCTTG GCTCACTGCA ACTTCTGCCT 1620
CCCAGGTTCA GGCGATTCTC CTGCCTCGGC CTCCTGAGTA GCTGGGATTA CAGGTGCCTG 1680
CCACCACACC CGGCTAATTT TTGTAATTTT AGTAGAGACG GGGTTTCACC ATGTTGGCCA 1740
GGCTGGTCTC AAACTCCTGG GCTCAAGTGA TCCACCCGCC GCGCCCTCCG AAAGCGCTGG 1800
GATTACAGGC TCCAGCAACC ACGCCAGGTC GCCTCTCTCG TTTTTATTCT CTCTTCCTCT 1860
ATCTGTCTTT TTTCTCTTTC TCCGTCTCTC TCCCTCTCTC TCGTTCTGTC TCCCCCGCCT 1920
GTCTCCCTCC CTCCCTCTTC CACTCTCCCT GCGTCTCTCC CTGTTTCTTT CTTTCCCCTT 1980
CTTCTCCTGT CCCGTCTGTC CCCTCTGTCC CTCTCTCTGT TCTTTTTTCT GTCTCTCCCT 2040
CCCTTTCTCT GGGCCTCTCC CTCCCTCTCT GTCTTCTCTC TGTCTCCCCC TCTCCGTTTC 2100
CCTCCCTATC TCTCCCTCCC TCTCTCCCTC CGTCTCTGTC TGTGTCTCTT TCTCTCTGTC 2160
TCTCCCCACT TGTCTTTCTA CCTCTCCTTC CTTCTCTCTC TGTGCCTCTT CTTCTCCCCG 2220
TCCCTCCACG TCCCCCGTGT 2240